CLINICAL_TRIALS
trial_result
· 2007-11-09
Clinical Trial Update: Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension [Phase 3]
Summary
Clinical trial update announcing the completion of a Phase 3 safety and efficacy study of sitaxentan (Thelin) in pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Encysive Pharmaceuticals | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED